AIM IMMUNOTECH INC. Proceeds from Insurance Settlement, Investing Activities
AIM IMMUNOTECH INC. (AIM) reported Proceeds from Insurance Settlement, Investing Activities of -$1.63 million for the 12-month period ending 2016-12-31, per its 10-K filed 2018-03-30.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromInsuranceSettlementInvestingActivities · last filed 2018-03-30
- AIM IMMUNOTECH INC. proceeds from insurance settlement, investing activities for the quarter ending 2016-12-31 was $0.00.
- AIM IMMUNOTECH INC. proceeds from insurance settlement, investing activities for the quarter ending 2016-09-30 was -$190.00K.
- AIM IMMUNOTECH INC. proceeds from insurance settlement, investing activities for the quarter ending 2016-06-30 was -$1.44M.
- AIM IMMUNOTECH INC. proceeds from insurance settlement, investing activities for fiscal 2016 was -$1.63M.
| Period end | Proceeds from Insurance Settlement, Investing Activities 3 month | Proceeds from Insurance Settlement, Investing Activities 6 month | Proceeds from Insurance Settlement, Investing Activities 9 month | Proceeds from Insurance Settlement, Investing Activities 12 month |
|---|---|---|---|---|
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-30 | -$190.00K derived: sum of 2 quarters · filed 2018-03-30 | -$1.63M derived: sum of 3 quarters · filed 2018-03-30 | -$1.63M 10-K · filed 2018-03-30 |
| 2016-09-30 | -$190.00K 10-Q · filed 2016-11-14 | -$1.63M derived: sum of 2 quarters · filed 2016-11-14 | -$1.63M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | -$1.44M 10-Q · filed 2016-08-15 | -$1.44M 10-Q · filed 2016-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |